Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment - European Medical Journal | Immunology and Biotherapies | Scoop.it
This review summarises the characteristics of rituximab and other anti-CD20 monoclonal antibodys for NHL treatment.

Via Krishan Maggon